NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s traded shares stood at 85962.0 during the last session, with the company’s beta value hitting 1.64. At the close of trading, the stock’s price was $1.91, to imply an increase of 0.53% or $0.01 in intraday trading. The NRSN share’s 52-week high remains $2.60, putting it -36.13% down since that peak but still an impressive 73.3% since price per share fell to its 52-week low of $0.51. The company has a valuation of $45.82M, with an average of 0.28 million shares in intraday trading volume over the past 10 days and average of 274.12K shares over the past 3 months.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN) trade information
After registering a 0.53% upside in the last session, NeuroSense Therapeutics Ltd (NRSN) has traded red over the past five days. The 5-day price performance for the stock is -3.54%, and 9.77% over 30 days. With these gigs, the year-to-date price performance is 76.85%. Short interest in NeuroSense Therapeutics Ltd (NASDAQ:NRSN) saw shorts transact 0.39 million shares and set a 0.89 days time to cover.
NeuroSense Therapeutics Ltd (NRSN) estimates and forecasts
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 2.71% for the past 5-year period. While 2025 is set for a 16.83% return in earnings, projections for the next 5 years are at 27.32% annually.
NRSN Dividends
NeuroSense Therapeutics Ltd has its next earnings report out on 2025-Apr-07. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
NeuroSense Therapeutics Ltd (NASDAQ:NRSN)’s Major holders
NeuroSense Therapeutics Ltd insiders hold 30.98% of total outstanding shares, with institutional holders owning 0.81% of the shares at 1.18% float percentage. In total, 0.81% institutions holds shares in the company, led by ARMISTICE CAPITAL, LLC. As of 2024-06-30, the company held over 1.58 million shares (or 10.2822% of shares), all amounting to roughly $1.77 million.
The next major institution holding the largest number of shares is MEITAV INVESTMENT HOUSE LTD with 40000.0 shares, or about 0.2597% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $44800.0.
